Showing results (1581-1590 of 4,124) with videos related to
Sort By:
Pageof 413
Human Gene Therapy|February 1, 1995
Correction of the growth defect in dwarf mice with nonautologous microencapsulated myoblasts--an alternate approach to somatic gene therapyA al-Hendy, G Hortelano, G S Tannenbaum, et al.Human Gene Therapy|February 1, 1995
Human immunodeficiency virus type 2 (HIV-2): packaging signal and associated negative regulatory elementA Garzino-Demo, R C Gallo, S K AryaHuman Gene Therapy|December 1, 1994
Delivery of a secretable adenosine deaminase through microcapsules--a novel approach to somatic gene therapyM Hughes, A Vassilakos, D W Andrews, et al.Human Gene Therapy|June 1, 1994
Evaluation of the efficacy and safety of in vitro, adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNAN Mittereder, S Yei, C Bachurski, et al.Human Gene Therapy|August 1, 1994
Transduction of human bone marrow by adenoviral vectorK Mitani, F L Graham, C T CaskeyHuman Gene Therapy|August 1, 1994
Effect of exogenous nerve growth factor on neurotoxicity of and neuronal gene delivery by a herpes simplex amplicon vector in the rat brainP Pakzaban, A I Geller, O IsacsonHuman Gene Therapy|November 1, 1994
Molecular and virological effects of intracellular anti-Rev single-chain variable fragments on the expression of various human immunodeficiency virus-1 strainsL Duan, H Zhang, J W Oakes, et al.Human Gene Therapy|November 1, 1994
Persistent erythropoiesis by myoblast transfer of erythropoietin cDNAY Hamamori, B Samal, J Tian, et al.Human Gene Therapy|July 20, 2007
Quiescent subpopulations of human CD34-positive hematopoietic stem cells are preferred targets for stable recombinant adeno-associated virus type 2 transductionHelicia Paz, Christie A Wong, Wei Li, et al.Human Gene Therapy|September 1, 2007
Characterization of a bipartite recombinant adeno-associated viral vector for site-specific integrationC Zhang, N G Cortez, K I BernsPageof 413